240 related articles for article (PubMed ID: 17245225)
1. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
[No Abstract] [Full Text] [Related]
2. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Mutimer D; Pillay D; Cook P; Ratcliffe D; O'Donnell K; Dowling D; Shaw J; Elias E; Cane PA
J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
[TBL] [Abstract][Full Text] [Related]
3. Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.
Matthews GV; Pillay D; Cane P; Ratcliffe D; Gazzard B; Nelson M
Clin Infect Dis; 2001 Dec; 33(12):2049-54. PubMed ID: 11698987
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment of hepatitis B].
Suárez García E; Romero Gómez M; Grande Santamaría L
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
[No Abstract] [Full Text] [Related]
5. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Van Bömmel F; Schernick A; Hopf U; Berg T
Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
[No Abstract] [Full Text] [Related]
6. The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
Puoti M; Cozzi-Lepri A; Ancarani F; Bruno R; Ambu S; Ferraro T; Tundo P; Santantonio T; Toti M; Bonasso M; d'Arminio Monforte A; ;
Antivir Ther; 2004 Oct; 9(5):811-7. PubMed ID: 15535419
[TBL] [Abstract][Full Text] [Related]
7. Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
Mancuso A; Pagliaro L
Am J Gastroenterol; 2002 May; 97(5):1268-9. PubMed ID: 12014746
[No Abstract] [Full Text] [Related]
8. Treatment of recurrence of hepatitis B in transplant patients.
Berenguer M; Wright TL
J Hepatol; 2003; 39 Suppl 1():S190-3. PubMed ID: 14708702
[No Abstract] [Full Text] [Related]
9. [New management of hepatitis B virus].
Sata M; Kumashiro R
Nihon Naika Gakkai Zasshi; 1999 Apr; 88(4):713-7. PubMed ID: 10341661
[No Abstract] [Full Text] [Related]
10. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Berg T; Neuhaus R; Müller AR; Hopf U; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13(4):290-6. PubMed ID: 10959482
[TBL] [Abstract][Full Text] [Related]
11. Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
Wolters LM; Hansen BE; Niesters HG; de Man RA
Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1007-11. PubMed ID: 12352221
[TBL] [Abstract][Full Text] [Related]
12. Primary infection with a lamivudine-resistant hepatitis B virus.
Thibault V; Aubron-Olivier C; Agut H; Katlama C
AIDS; 2002 Jan; 16(1):131-3. PubMed ID: 11741175
[No Abstract] [Full Text] [Related]
13. Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
Schnepf N; Sellier P; Bendenoun M; Zini JM; Sanson-le Pors MJ; Mazeron MC
J Clin Virol; 2007 May; 39(1):48-50. PubMed ID: 17368969
[TBL] [Abstract][Full Text] [Related]
14. Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
Henkes M; Martin S; Einsele H; Aulitzky WE
Ann Hematol; 2002 Jun; 81(6):343-6. PubMed ID: 12107567
[TBL] [Abstract][Full Text] [Related]
15. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B.
Lim SG; Wai CT; Rajnakova A; Kajiji T; Guan R
Gut; 2002 Oct; 51(4):597-9. PubMed ID: 12235087
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus kinetics and mathematical modeling.
Perelson AS; Ribeiro RM
Semin Liver Dis; 2004; 24 Suppl 1():11-6. PubMed ID: 15192796
[TBL] [Abstract][Full Text] [Related]
17. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
[TBL] [Abstract][Full Text] [Related]
18. Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.
Thabut D; Thibault V; Benhamou Y; Bernard B; Aubron-Olivier C; Poynard T; Di Martino V
AIDS; 2001 Dec; 15(18):2463-4. PubMed ID: 11774835
[No Abstract] [Full Text] [Related]
19. Chronic hepatitis B, biological basis for new therapeutic strategies.
Dianzani F
J Biol Regul Homeost Agents; 1999; 13(2):71-9. PubMed ID: 10503729
[No Abstract] [Full Text] [Related]
20. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
Tang S; Ho SK; Moniri K; Lai KN; Chan TM
Transplantation; 2002 Jan; 73(1):148-51. PubMed ID: 11792996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
